1177. Meet-the-Professor
Session: Meet-the-Professor Session: Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges
Saturday, October 5, 2013: 7:35 AM
Room: The Moscone Center: 250-262
John Powers, MD, FIDSA, Medicine, George Washington University School of Medicine, Bethesda, MD

John H. Powers, MD, FACP, FIDSA
Biographical Sketch:
Dr. Powers is a Senior Medical Scientist with Scientific Applications International Corporation in support of the Collaborative Clinical Research Branch at the National Institute of Allergy and Infectious Diseases/National Institute of Health. Prior to his current position Dr. Powers was the Lead Medical Officer for Antimicrobial Drug Development and Resistance Initiatives in the Office of Antimicrobial Products, Center for Drug Evaluation and Research, at the US Food and Drug Administration where he was responsible for issues related to clinical trials and policy in antimicrobial research. Dr. Powers was a co-chair for the Inter-Agency Task for on Antimicrobial Resistance of 11 federal agencies responsible for implementing the Public Health Action Plan to Combat Antimicrobial Resistance. Prior to joining the FDA, Dr. Powers was assistant professor in the Division of Infectious Diseases at the University of Maryland School of Medicine. He is currently an Assistant Clinical Professor of Medicine at the University of Maryland as well as an Assistant Clinical Professor of Medicine at the George Washington University School of Medicine. Dr. Powers also actively sees patients and attends on the infectious diseases service at the clinical center at NIH.
Dr. Powers received his bachelorís degree and graduated magna cum laude from the University of Pennsylvania. He received his medical degree and residency training from Temple University School of Medicine, where he also served as Chief Resident. He completed his infectious diseases training at the University of Virginia School of Medicine. Dr Powers is board certified in internal medicine and infectious diseases.
Dr. Powers has been an investigator on over 50 clinical trials. He is a fellow in the American College of Physicians and the Infectious Diseases Society of America, and a member of IDSAís Research in Resistance Working Group. He has also authored several book chapters and published several papers on clinical trial design in the study of infectious diseases. He has won several awards for teaching medical students, residents and fellows. In addition, he is on the editorial board of Antimicrobial Agents and Chemotherapy, as well as a reviewer for several other scientific journals.

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.